Funding Rounds
ENYO Pharma

ENYO Pharma Series B (2018, $43M)

ENYO Pharma

Vonafexor drug maker for the treatment of Alport syndrome.

View Company Profile

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Summary

Stage: Series B

Raised Amount: $43.80M

Raised Date: 2018-04-01

Investors